These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 23290428

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study.
    Bullarbo M, Orrskog ME, Andersch B, Granström L, Norström A, Ekerhovd E.
    Am J Obstet Gynecol; 2007 Jan; 196(1):50.e1-5. PubMed ID: 17240231
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S for cervical ripening before first trimester curettage.
    Chen FC, Bergann A, Krosse J, Merholz A, David M.
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):176-9. PubMed ID: 17980952
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A, Mittal S, Taneja BK, Singal N, Attri S.
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
    Ting WH, Peng FH, Lin HH, Lu HF, Hsiao SM.
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
    [Abstract] [Full Text] [Related]

  • 31. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
    Nicoll AE, Mackenzie F, Greer IA, Norman JE.
    Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening at 41 weeks' gestation: A randomized controlled trial.
    Rameez MF, Goonewardene IM.
    J Obstet Gynaecol Res; 2007 Aug; 33(4):452-6. PubMed ID: 17688611
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of isosorbide mononitrate for cervical ripening before surgical termination of pregnancy in the first trimester.
    Phusaanantakul P, Promsonthi P, Chanrachakul B.
    Int J Gynaecol Obstet; 2010 Aug; 110(2):145-8. PubMed ID: 20580361
    [Abstract] [Full Text] [Related]

  • 36. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK, Mukherji J, Kamilya GS, Ray S, Hazra A.
    Acta Obstet Gynecol Scand; 2006 Aug; 85(12):1458-62. PubMed ID: 17260222
    [Abstract] [Full Text] [Related]

  • 37. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
    [Abstract] [Full Text] [Related]

  • 38. Evaluating the efficacy of outpatient use of isosorbide mononitrate on cervical ripening in pregnant women with unfavourable cervix.
    Kashanian M, Jangjoo S, Sheikhansari N, KaramiAbd T.
    J Obstet Gynaecol; 2021 Aug; 41(6):876-880. PubMed ID: 33225782
    [Abstract] [Full Text] [Related]

  • 39. Randomised controlled trial of the efficacy of misoprostol used as a cervical ripening agent prior to termination of pregnancy in the first trimester.
    de Jonge ET, Jewkes R, Levin J, Rees H.
    S Afr Med J; 2000 Mar; 90(3):256-62. PubMed ID: 10853403
    [Abstract] [Full Text] [Related]

  • 40. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y, Chanrachakul B, Punyavachira P.
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.